Clinical Trial Update: A Phase III Study on the Safety, Pharmacokinetics and Efficacy of Coagulation Factor VIIa [Phase 3]

View source ↗

Summary

Phase III study assessing safety, pharmacokinetics, and efficacy of coagulation Factor VIIa in hemophilia A and B with inhibitors has completed with posted resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia with Inhibitors

Drugs mentioned

• Coagulation Factor VIIa (Factor VIIa)

Snippet

Sponsor: Laboratoire français de Fractionnement et de Biotechnologies | Conditions: Hemophilia A With Inhibitors, Hemophilia B With Inhibitors | Phase 3 | Status: COMPLETED | Results posted: 2020-08-28